HHSN2612015000241 period of performance: 9/15/16 to 10/14/2018 preclinical evaluation of a new lipid-based smedds
Ended Awarded Last action
- Contract number
- HHSN26100003
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5 Part of Illinois Institute Of Technology
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $321,111
Award facts
- Opportunity
-
- N01CN4500945 Solicitation number
- Preclinical PREVENT Cancer Program- Toxicology and Pharmacology Testing Award Notice · Posted Sep 26, 2015
- Contract value 100% obligated
- $321,110.80 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Chicago, IL 60616, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,870 | |
| Other Administrative Action | $0 | |
| Change Order | $60,976 | |
| Other Administrative Action | $0 | |
| Original award | $262,005 |
About this award
This federal contract award with award ID HHSN261201500024I|HHSN26100003 was issued by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS). The $321,110.80 award was made on September 15, 2016 to the IIT Research Institute (IITRI), a non-profit research organization and division of the Illinois Institute of Technology (IIT).
The contract is for the "PRECLINICAL EVALUATION OF A NEW LIPID-BASED SMEDDS" under the NCI's PREVENT Toxicology and Pharmacology Testing (PREVENT TOX) program, which supports preclinical development of cancer therapies. The period of performance is from September 15, 2016 to October 14, 2018, with an ultimate completion date of March 19, 2022. The contract is a cost-plus-fixed-fee Delivery Order under the PREVENT TOX IDIQ contract vehicle. There was no set-aside designation used for this award.
Quick answers
Who was awarded contract HHSN26100003?
HHSN26100003 was awarded to IIT Research Institute by National Cancer Institute (National Institutes of Health) on September 15, 2016.
How much is contract HHSN26100003 worth?
The government has obligated $321,111 on HHSN26100003.
Is contract HHSN26100003 an order under another contract?
Yes. HHSN26100003 is a delivery order under HHSN261201500024I, an indefinite delivery contract, on PREVENT Toxicology and Pharmacology Testing (PREVENT TOX).
Was contract HHSN26100003 competed?
The extent of competition for HHSN26100003 was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award